Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Apitox, Honeybee Toxin for Pain and Inflammation of Osteoarthritis

ClinicalTrials.gov ID: NCT01112722

Public ClinicalTrials.gov record NCT01112722. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 3, 2026, 7:09 AM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double Blind, Active Controlled, Parallel Group, Clinical Study, to Evaluate the Safety and Efficacy of Apitox vs Histamine in Subjects With Refractory Osteoarthritis Pain and Inflammation of the Knee

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The study will identify the efficacy of Apitox, purified honeybee toxin, in 330 patients with diagnosed osteoarthritis of the knee. The subjects will be evaluated for relief of pain using Western Ontario and McMaster Osteoarthritis Index (WOMAC) and Physician and Patient Global Assessments and primary efficacy measure of relief of pain and inflammation over a 12 week treatment period after randomization into the trial. Secondary efficacy is improvement of mobility Treatment effect will be compared in a 2-1 Apitox vs active control

Study identification

NCT ID
NCT01112722
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Apimeds, Inc.
Industry
Enrollment
363 participants

Conditions and interventions

Eligibility (public fields only)

Age range
30 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2013 (Type not available)
Primary completion
Nov 2016 (Actual)
Completion
Dec 2016 (Actual)
Last update posted
Dec 13, 2016

2013 – 2016

United States locations

U.S. sites
15
U.S. states
9
U.S. cities
14
Facility City State ZIP Site status
Functional Research LLC Gulf Shores Alabama 36542 —
Tucson Orthopaedic Institute Tucson Arizona 87512 —
SC Clinical Research Inc. Garden Grove California 92844 —
Axis Clinical Trials Los Angeles California 90036 —
Westlake Medical Research Thousand Oaks California 91360 —
SC Clinical Research Inc. Upland California 91786 —
Schrock Orthopedics Research Fort Lauderdale Florida 33316 —
AppleMed Research Inc. Miami Florida 33155 —
Radiant Research Inc. Pinellas Park Florida 33781 —
Beacon Clinical Brockton Massachusetts 02301 —
Radiant Research Inc Columbus Columbus Ohio 43212 —
Hillcrest Clinical Research Olahoma City Oklahoma 73119 —
PMG Research of Knoxville Knoxville Tennessee 37912 —
PMG Research of Knoxville Knoxville Tennessee 37938 —
Tekton Research Austin Texas 78745 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01112722, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 13, 2016 · Synced Nov 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01112722 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →